Soru

Zorluk: OrtaPsychopharmacology and Psychological Therapies

A 24-year-old man is diagnosed with schizophrenia after presenting with a 7-month history of auditory hallucinations and persecutory delusions. His psychiatrist is planning a long-term pharmacotherapy strategy. Assuming the patient exhibits an inadequate clinical response to each consecutive intervention despite optimal dosing and confirmed medication adherence, arrange the following treatment steps in the correct standard algorithm for the management of schizophrenia.

  1. 1Initiate a trial of a first-line second-generation antipsychotic (e.g., risperidone).
  2. 2Switch to a trial of an alternative first-line antipsychotic (e.g., aripiprazole).
  3. 3Initiate a trial of clozapine with absolute neutrophil count (ANC) monitoring.
  4. 4Augment clozapine with an additional agent (e.g., electroconvulsive therapy or a second antipsychotic).

Cevap

The correct sequence begins with a first-line antipsychotic, followed by an alternative first-line agent, then clozapine for treatment resistance, and finally clozapine augmentation.
The standard treatment algorithm for schizophrenia dictates that patients begin with a first-line antipsychotic. If the first trial fails due to lack of efficacy or intolerability, a different first-line antipsychotic should be tried. Only after two adequate trials of different antipsychotics fail is a patient diagnosed with treatment-resistant schizophrenia, for which clozapine is the gold standard. If clozapine monotherapy is insufficient, augmentation with ECT or another agent is the final step.

Adım Adım Çözüm

1
Identify the first step in pharmacological management for a newly diagnosed patient with schizophrenia.
Initiate a trial of a first-line second-generation antipsychotic (e.g., risperidone).
Second-generation antipsychotics are the preferred initial treatment due to a lower risk of extrapyramidal symptoms compared to first-generation agents.
2
Determine the next management step following a single failed adequate medication trial.
Switch to a trial of an alternative first-line antipsychotic (e.g., aripiprazole).
Treatment-resistant schizophrenia requires the failure of at least two antipsychotics. Therefore, a second trial with a different standard agent is indicated before moving to clozapine.
3
Identify the threshold and treatment for treatment-resistant schizophrenia.
Initiate a trial of clozapine with absolute neutrophil count (ANC) monitoring.
After failing two adequate trials of different antipsychotics, the patient is considered treatment-resistant. Clozapine is the only evidence-based medication for this stage.
4
Determine the strategy for a patient who has an inadequate response to optimized clozapine monotherapy.
Augment clozapine with an additional agent (e.g., electroconvulsive therapy or a second antipsychotic).
If clozapine monotherapy fails, augmentation strategies such as adding a second antipsychotic, a mood stabilizer, or electroconvulsive therapy (ECT) are employed.

Anahtar Kavram

The pharmacological treatment algorithm for schizophrenia progresses from a first-line antipsychotic to an alternative first-line antipsychotic, followed by clozapine (after two failed trials), and finally clozapine augmentation.
Tahmini Süre:1m 30s
Bu soruyu puanla